Infective Endocarditis
-
Upload
tok-keawkaew -
Category
Documents
-
view
91 -
download
1
Transcript of Infective Endocarditis
![Page 1: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/1.jpg)
Infective Endocarditis
Amonthep Waipara
![Page 2: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/2.jpg)
Endocarditis• An inflammation of the endocardium,
Which is the membranes lining the chamberof the heart and covering the cusps of the heart valves.
![Page 3: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/3.jpg)
Endocarditis• Infection of the heart valves by
various microorganisms.• Average motality is 20%• Classified by clinical presentation:–Acute bacterial endocarditis (ABC)–Subacute bacterial endocarditis
(SBC)
![Page 4: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/4.jpg)
Infection
ABE SBE
Symptoms Fulminating, high fever,
WBC systemic toxicity
Indolent, fatigue,
weakness,low grade
fever, wt lossValves
involved native Preexisting
valvular heart disease or prosthetic
Caused S.aureus (virulent)
Streptococcus pyogens,
s.pneumoiae
Viridans strep (less invasive),
Staphylococcus
epidermidisUntreated Death to < 6
wkDeath 6 wk-3
mo
![Page 5: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/5.jpg)
Problem associated with this classification
• Overlap clinical presentation and the course of disease
• Ignore many nonbacterial causes of endocarditis: chlamydiae, rickettsiae, and fungi
![Page 6: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/6.jpg)
Classification of IE
Native-valve IE• Congenital
heart disease• Rheumatic
heart disease• Degenerative
valve lesion
Posthetic valve IE
• Eaely (w/n 60 day after Sx)
• Late (after 60 day of Sx)
IE in IVDU Nosocomial IE
![Page 7: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/7.jpg)
Posthetic – valve EndocarditisEaely infection
• S. epidermidis• S. aureus
Late infection
• Streptococci• HACEK
![Page 8: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/8.jpg)
IE in IVDU
• Occurs in young people (30-40 years old)• Valve affected:– Tricuspid (>50%) > Aortic (25%) > Mitral (20%)
• HIV-infected : 4-fold increased risk in CD4 < 200 cell/mcl
• Etiology:– S.aureus, P. aeruginosa, fungi– HIV pts: bartonella, salmonella,Listeria
![Page 9: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/9.jpg)
Nosocomial IE
• About 22% pts with IE• Etiology:– S.aureus, enterococci
• Frequently associated with – Catheters or medicosurgical procedures
• Mortality rate: >50%
![Page 10: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/10.jpg)
Pathogenesis Damaged endothelial surface of the heart
Deposition of platelets and fibrin on the surface
Nonbacterial Thrombotic Endocarditis (NBTE)
Bacteria adheres to damaged valve completeted w/n minutes during transient bacteremia
A vegetation of fibrin, platelets, and bacteria form
![Page 11: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/11.jpg)
![Page 12: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/12.jpg)
Site of Involvement
• Determined by the underlying cardiac defect and the infecting organisms.– Mitral valve : VS (85%)– Tricuspid value : Staphylococci and IVDU– Mitral > Aortic > Tricuspid> pulmonic valves
![Page 13: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/13.jpg)
Complications
• Cardiac complications– Heart failure
• Neurologic complications– Ischemic stroke– Intracranial hemorrhage – S.aureus
• splenomegaly
![Page 14: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/14.jpg)
Risk factors
• โรคลิ้��นหัวใจผิ�ดปกติ�• การใส่�ลิ้��นหัวใจเที�ยม• Previous IE• ม�หัวใจผิ�ดปกติ�มาติ�งแติ�ก�าเน�ด• คนที��เป�นโรคหัวใจร�มาติ�ก (rheumatic heart disease)• Hypertrophic cardiomyophathy• Mitral valve prolapsed with regurgitation• พวกที��ที�า Hemodialysis หัร!อพวกที��ม�การน�าเลิ้!อดเข้$าออก
จากร�างกาย• IVDU
![Page 15: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/15.jpg)
Etiologic Organisms IE
• Streptococci 55-62• Viridans streptococci 30-40• Other streptococci 15-25
• Enterococci 5-18• Staphylococci 20-35
• Coagulase positive 10-27• Coagulase negative 1-3
• Gram –ve aerobic bacteria 1.5-13• Fungi 2-4• Miscellaneous bacteria <5• Mixed infection 1-2• Culture negative< 5-24
![Page 16: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/16.jpg)
ส่าเหัติ% native-valve แลิ้ะ prosthetic-valve endocarditis
![Page 17: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/17.jpg)
Incidence(%) of bact.
• Dental มกจะพบติรงน��เป�นส่�วนมาก• การถอนฟั+น 18-85• การผิ�าฟั+น 32-88• การเค��ยวลิ้�กอม 17-51• การแปรฟั+น 0-26• การใส่�พวกอ%ปกรณ์-ที�าฟั+น 27-50
• Upper airway• การที�า bronchoscopy 15• การผิ�าทีอนซิ�ลิ้ 28-38• การที�า suction 16
![Page 18: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/18.jpg)
Objective findings of IE(%)
Fever 90Splenomegaly 20-57Mycotic aneurysm 20Clubbing 12-
52Retinal lesion 2-10Sign of Renal
Failure 10-15
Heart murmur 85Changing murmur 5-
10New murmur 3-5Embolic phenomenon >50Skin manifestation 18-50
• Osler node• Splinter hemorrhages • Petechiae• Janeway lesion
![Page 19: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/19.jpg)
Splinter hemorrhages
Osler node
PetechiaeJaneway lesion
![Page 20: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/20.jpg)
![Page 21: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/21.jpg)
Laboratory Finding
Lab ABE SBE
WBC Elevated Elevated
ESR Elevated Elevated
Other Normocytic, normochromic anemia, low SFe
![Page 22: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/22.jpg)
Blood Cultures
• Hallmark “Continuous bacteremia”, caused by bacteria shedding from the vegetation into the blood stream.
• 3 set, each from separate site, should be collected over 24 hr.
![Page 23: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/23.jpg)
Blood Cultures
• +ve result: 95% of bacterial endocarditis50% of fungal endocarditis
• False negative: – Prior antibiotics (culture-negative endocarditis)-
suppress pathogen’s growth– Fastidious organisms
![Page 24: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/24.jpg)
Echocardiography
• To identify and localize valvular lesions• Transthoracic Echocardiography (TTE)– Sensitivity 60-65%
• Transesophageal Echocardiography (TEE)– Sensitivity 95%– Use when – ve blood cultures– Recommended in pts:
• With prosthetic valves• Rated as possible IE by clinical criteria• With complicated IE (paravalvular abscess)
![Page 25: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/25.jpg)
Echocardiographic finding
• + ve result :– A large vegetation (>1cm), a ring abscess, or
intracardiac fistula– Alert for monitoring complications: septic emboli
and HF• - ve result– Does not exclude endocarditis
![Page 26: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/26.jpg)
Diagnosis
• Signs and symptoms : nonspecific• Lab: nonreliable• Diagnostic criteria: Duke criteria• Blood culture: identify infecting pathogens• TEE: determine the presence of valvular
vegetation
![Page 27: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/27.jpg)
![Page 28: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/28.jpg)
![Page 29: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/29.jpg)
![Page 30: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/30.jpg)
Treatment
• Desired outcome– Relieve the S&S of the disease– Eradicate the causative organism with minimal drug
exposure– Provide cost-effective abx therapy, determined by:
• The likely or identified pathogen• Drug susceptibilities• Hepatic and renal function• Drug allergies• Anticipated drug toxicities
![Page 31: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/31.jpg)
To eradicate causative organism
• High-dose IV (bactericidal) antibiotics– Serum concentration > Minimal Bactericidal
concentration(MBC) • The synergistic combination may be needed
for some organisms– To complete more rapid and complete bactericidal
effects– Weigh risk and benefit
![Page 32: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/32.jpg)
Antibiotic UsePCN G DOC for streptococciNaf- / Oxa- / cloxacillin
DOC for staphylococci
Ampicillin DOC for enterococciGentamicin Synergitic effect for
enterococci hhasten the pace of cure (strep & staphy)Prevent emergence of resistant org(PVE caused by coagulase –ve staphy)
Vancomycin Reserved for resistant orgs and pts with immediate B-lactam allergies
![Page 33: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/33.jpg)
Nonpharmacologic Treatment
• Valve replacement surgery:– Large vegetation (> 10mm)– >1 embolic event during 1st 2 wk of tx– Severe valvular insufficiency– Valvular perforation or dehiscence– Decompensated heart faliure, perivalvular or
myocardial abscess– New heart block– Persistent fever or bactermia
![Page 34: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/34.jpg)
Viridans streptococci
• The most etiologic agents in SBE (native valves) and non injection drug users.
• A large number of different species– Streptococcus sanguis– Streptococcus oralis (mitis)– Streptococcus salivarius– Streptococcus mutans– other
![Page 35: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/35.jpg)
Tx of Native Valve Endocarditis due to Highly PCN-S-Viridans streptococci & S. bovis(MIC <0.12 mcg/mL)
Antibiotic Dosage ,Route Duration
Aq. PCN G Naorceftriaxone
12-18 mU/d IV 4 wk
2 g once daily IV/IM 4 wk
Aq. PCN G Na+gentamicin
12-18 mU/d IV 2 wk
3 mg/kg IM/IV od 2 wk (Pk 3; Tr<1)
Ceftriaxone +gentamicin
2 g IV/IM od 2 wk
3 mg/kg IM/IV od 2 wk(Pk 3; Tr<1)
Vancomycin HCl (for pt all to B-lactams)
15 mg/kg (not 2 g/d) IV q 12(infused > 1 hr)
4 wk(Pk 30-45)
![Page 36: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/36.jpg)
Tx of Native Valve Endocarditis due to Highly PCN-Relatively-R-
Viridans Streptococci & S. bovis(MIC >0.12,< 0.5 mcg/mL) Antibiotic Dosage ,Route Duration
Aq. PCN G Na+gentamicin
24 mU/d IV 4 wk
3 mg/kg IM/IV od 2 wk (Pk 3; Tr<1)
Ceftriaxone +gentamicin
2 g IV/IM od 4 wk
3 mg/kg IM/IV od 2 wk(Pk 3; Tr<1)
Vancomycin HCl (for pt all to B-lactams)
15 mg/kg (not 2 g/d) IV q 12(infused > 1 hr)
4 wk(Pk 30-45)
![Page 37: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/37.jpg)
Antibiotic Dosage ,Route DurationAq. PCN G Na+gentamicin
18-30 mU/d IV (q4) 4-6 wk
1 mg/kg IM/IV q8 4-6 wk (Pk 3; Tr<1)
Ampicillin Na+gentamicin
12 g/d IV (2g q4) 4-6 wk
1 mg/kg IM/IV q8 4-6 wk Pk 3; Tr<1)
Vancomycin HCl (for pt all to B-lactams)+gentamicin
15 mg/kg (not >2 g/d) IV q 12
4-6 wk (Pk 30-45)
1 mg/kg IM/IV q8 4-6 wk(Pk 3; Tr<1)
Tx for Endocarditis due to PCN/Gent/Van-S-Enterococci
• This table is also for VS with MIC of> 0.5 mcg/mL, Abiotrophia defcetiva and Granulicatella spp, or prosthetic valve endocarditis caused by VS or S. bovis
![Page 38: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/38.jpg)
Tx for Endocarditis due to PCN/Van-S, Gent-R-Enterococci
• This table is also for VS with MIC of> 0.5 mcg/mL, Abiotrophia defcetiva and Granulicatella spp, or prosthetic valve endocarditis caused by VS or S. bovis
Antibiotic Dosage ,Route DurationAq. PCN G Na+streptomycin
24 mU/d IV (q4) 4-6 wk
7.5 mg/kg IM/IV q12 4-6 wk
Ampicillin Na+streptomycin
12 g/d IV (2g q4) 4-6 wk
7.5 mg/kg IM/IV q12 4-6 wk
Vancomycin HCl (for pt all to B-lactams)+streptomycin
15 mg/kg (not >2 g/d) IV q 12
6 wk (Pk 30-45)
7.5 mg/kg IM/IV q12 6 wk
![Page 39: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/39.jpg)
Tx for Endocarditis due to AMG/Van-S, PCN-R-Enterococci
Antibiotic Dosage ,Route DurationAmpicillin Na+gentamicin
3 g IV q 6 6 wk
1 mg/kg IM/IV q8 6 wk
Vancomycin HCl (for pt all to B-lactams)+gentamicin
15 mg/kg (not >2 g/d) IV q 12
6 wk
1 mg/kg IM/IV q8 6 wk
![Page 40: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/40.jpg)
Tx for Endocarditis due to AMG/Van/PCN-R-Enterococci
Antibiotic Dosage ,Route DurationE. faeciumLinezolid 600 mg PO/IV q12 > 8wkE. faecalisImipenam +Ampicillin Na
500 mg IV q 6 > 8wk2 g IV q 4 > 8wk
Ceftriaxone +Ampicillin Na
2 g IV/IM q 12 > 8wk
2 g IV q 4 > 8wk
![Page 41: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/41.jpg)
Staphylococci
• S. aureus – IVDU (60-90% of cases), prosthetic heart valve– Does not require a cardiac defect to be infective – More acute onset– Require immediate abx Tx
• S. epidermidis – Prothetic heart valve– Mostly MRSE
![Page 42: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/42.jpg)
Tx of Native Valve Endocarditis due to Staphylococcus
Antibiotic Dosage ,Route DurationMethicillin-Susceptible- Staphylococcus
For non B-lactam – allergic patient
Cloxacillin+gentamicin
2 g IV q 4 6 wk
1 mg/kg IM/IV q 8 3-5 d
For penicillin-allergic pts (nonanaphy lactoid type)
Cefazolin + gentamicinVancomycin
2 g IV q 8 6 wk
1 mg/kg IM/IV q 8 3-5 d
15 mg/kg IV q 12 6 wk
Methicillin-Resistant- Staphylococcus
Vancomycin HClDaptomycin
15 mg/kg IV q 12 6 wk
6 mg/kg IV od 6 wk
![Page 43: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/43.jpg)
IVDU
• Cloxacillin 2 g IV q 4 h + Amikacin 7.5 mg/kg IV q 12 h
• 2 week
![Page 44: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/44.jpg)
Tx of Prosthetic Valve Endocarditis due to Staphylococcus
Antibiotic Dosage ,Route DurationMethicillin-Susceptible- Staphylococcus
CloxacillinRifampicin+gentamicin
2 g IV q 4 > 6 wk
300 mg IV/PO q 8 > 6 wk
1 mg/kg IM/IV q 8 2 wk
Methicillin-Resistant- Staphylococcus
Vancomycin HClRifampicin+gentamicin
15 mg/kg IV q 12 > 6 wk
300 mg IV/PO q 8 > 6 wk
1 mg/kg IM/IV q 8 2 wk
![Page 45: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/45.jpg)
Prosthetic Valve Endocarditis
• Early– Occurs up to 1 yr after surgery– Caused by skin organisms which were implanted
at the time of surgery– SE(30%) > SA, gr-ve bacilli (10-20%)
• Late – Infection of the valve leaflet– Caused by same organism that are responsible for
native valve endocarditis
![Page 46: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/46.jpg)
HACEK Group
• Haemophilus parainfluenzae, Haemophilus aphrophilus
• Actinobacillus actinomycetamcomitans• Cardiobacterium hominis• Eikenella corrodens• Kingella kingae
![Page 47: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/47.jpg)
Tx for Endocarditis due to HACEKAntibiotic Dosage ,Route Duration
Ceftriaxone 2 g once daily IV/IM 4 wk
Ampi/sulbactam 12 g/d IV (3g q6) 4 wk
ciprofloxacin 500 mg PO q 12 4 wk
400 mg IV q 12
![Page 48: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/48.jpg)
Culture-nagtive endocarditis
• Cause:– Prior administration of Abx– Presence of slow-growing and fastidious org:
HACEK, Brucella, Coxiella, Chlamydiae, anaerobes, fungi
• Save blood culture for 3 wks to detect organism
![Page 49: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/49.jpg)
Culture-nagtive endocarditis
• Treatment– if hemodynamic unstable, start empiric abx
covering staphy and gr-ve bacilli, + antifungal agent
– If hemodynamic stable, withhold abx until culture become positive
![Page 50: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/50.jpg)
Endocarditis in HIV-seropositive pts
• Should not be given short – course regimens
![Page 51: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/51.jpg)
Fungal Endocarditis
• A life-threatening infection• Caused by Canndida and aspergillus sp.• Occurs primarily in:– IVDU– Patients with prosthetic heart valve– Immunocompromised pts– Those with IV catheters– Individual receiving broad-spectrum antibiotics
![Page 52: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/52.jpg)
Management of fungal endocarditis
• Early valve replacement • Aggressive fungicidal therapy– Amphotericin B 0.5-1 mg/kg/d IV (total 1.5-3
gm)for > 6 wks– Toxicities from above regimen: nephrotoxicity– Alternative : Fluconazole –safer, active againt
some Candida sp.• D/C broad spectrum Abx, if unnecessary
![Page 53: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/53.jpg)
Indications for Surgery
• Valve dysfunction with HF, perivalvular necrosis, aortic dissection, or valve orifice obstruction
• Persistent bacteremia or other evidence of failure despite appropiate abx Tx
• Most cases of early PVE• Endocarditis caused by resistant organisms
(Enterobacteriaceae, Pseudomonas, or fungi)• Local suppurative complication: myocardial
abscess, etc
![Page 54: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/54.jpg)
Monitoring during Tx
• Efficacy– Blood Cx,temp
• Safety – Depends on Abx
![Page 55: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/55.jpg)
Prevention
• Desired outcomes– Prevent IE in high-risk patients with appropriate
prohylactic antimicrobials
![Page 56: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/56.jpg)
Prophylactic Regimens for Dental Procedures Single dose regimen 30-60 min before procedure
Standard prophylaxis Amoxicillin PO A: 2 g, C: 50mg/kg
Unable to take PO Ampicillin IM/IV A: 2 g, C: 50mg/kg
Cefazolin/Ceftriaxone IM/IV A: 1 g, C: 50mg/kg
PCN-allergy Cephalexin PO A: 2 g, C: 50mg/kg
Clindamycin PO A: 600 mg, C: 20mg/kg
Azithromycin/Clarithromycin PO
A: 500 mg, C: 15 mg/kg
PCN-allergy and unable to take PO
Clindamycin IM/IV A: 600 mg, C: 20mg/kg
Cefazolin/Ceftriaxone IM/IV A: 1 g, C: 50mg/kg
![Page 57: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/57.jpg)
Respiratory procedures that need IE prophylaxis
• Incision or biopsy of the respiratory mucosa– Tonsillectomy– Adenoidectomy– Drainge of abscess or empyema
![Page 58: Infective Endocarditis](https://reader033.fdocuments.net/reader033/viewer/2022061107/544cb70cb1af9f310b8b461f/html5/thumbnails/58.jpg)
IE prophylaxis
• Is reasonable for procedures on respiratory tract or infected skin, skin structures, or musculoskeletal tissue only for patient with underlying cardiac conditions associated with the highest risk of adverse outcome from IE
• Is not recommend for GU or GI tract procedures